Dunhill Financial, LLC Astrazeneca PLC Transaction History
Dunhill Financial, LLC
- $383 Billion
- Q3 2025
A detailed history of Dunhill Financial, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Dunhill Financial, LLC holds 83 shares of AZN stock, worth $7,420. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83
Previous 71
16.9%
Holding current value
$7,420
Previous $4.97 Million
28.05%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,521Shares Held
502MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...